Literature DB >> 35978932

Pathophysiology of cognitive dysfunction and the role of combined brain/heart magnetic resonance imaging (Review).

George Markousis-Mavrogenis1, Flora Bacopoulou2,3, Genovefa Kolovou1, Maria-Roser Pons4, Aikaterini Giannakopoulou5, Antigoni Papavasiliou6, George D Kitas7, George P Chrousos3, Sophie I Mavrogeni1,3.   

Abstract

Normal cognitive function depends on a continuous and optimally regulated blood supply, and any pathology that further reduces cerebral blood perfusion in addition to that caused by aging could damage or destroy vulnerable neurons of the brain. Furthermore, glucose serves a crucial role as the primary fuel source for the mammalian brain and any disturbance in its circulating concentrations could directly affect brain function. The term cognitive dysfunction (CD), known also as 'brain fog', refers to deficits in attention, verbal and non-verbal learning, short-term and working memory, visual and auditory processing, mathematic problem solving, processing speed, focusing on a specific topic, and motor functioning. CD is the end-point of various cardiovascular, neural, metabolic and immune function impairments. Although CD has a serious impact on patient survival and quality of life, usually it is clinically underestimated. CD is currently assessed using cognitive tests (questionnaires), which have important limitations in their diagnostic capacity, specifically in the preclinical forms of CD. Cognitive tests may not identify subclinical cases of CD but diagnose CD only when symptoms are clinically overt. Furthermore, these tests do not provide information regarding the underlying pathophysiologic background of CD. The aim of the present review is to summarize the existing literature on CD and emphasize the role of combined brain-heart magnetic resonance imaging (MRI) in its early diagnosis, before CD questionnaires are abnormal. Combined brain/heart MRI has the potential to identify patients with CD at an early stage, facilitating risk stratification and early intervention. Furthermore, in parallel with brain assessment, it provides valuable information regarding the effect of the underlying disease on the myocardium. Equipment availability, physician familiarity and cost/effectiveness should be considered before wide clinical application of combined brain/heart MRI is recommended.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  brain; cardiovascular; chronic disease; cognitive dysfunction; cognitive function; dementia; heart; magnetic resonance imaging; neurological

Year:  2022        PMID: 35978932      PMCID: PMC9366250          DOI: 10.3892/etm.2022.11506

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.751


  105 in total

Review 1.  Neurocognitive function and cardiovascular disease.

Authors:  Shari R Waldstein; Carrington Rice Wendell
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Working and strategic memory deficits in schizophrenia.

Authors:  M Stone; J D Gabrieli; G T Stebbins; E V Sullivan
Journal:  Neuropsychology       Date:  1998-04       Impact factor: 3.295

3.  The dystrophin gene and cognitive function in the general population.

Authors:  Dina Vojinovic; Hieab H H Adams; Sven J van der Lee; Carla A Ibrahim-Verbaas; Rutger Brouwer; Mirjam C G N van den Hout; Edwin Oole; Jeroen van Rooij; Andre Uitterlinden; Albert Hofman; Wilfred F J van IJcken; Annemieke Aartsma-Rus; GertJan B van Ommen; M Arfan Ikram; Cornelia M van Duijn; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 4.  Neurodevelopmental Factors in Schizophrenia.

Authors:  Hanna Jaaro-Peled; Akira Sawa
Journal:  Psychiatr Clin North Am       Date:  2020-04-22

Review 5.  Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.

Authors:  M S Buchsbaum; E A Hazlett
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

6.  Development and validation of a brief dementia screening indicator for primary care.

Authors:  Deborah E Barnes; Alexa S Beiser; Anne Lee; Kenneth M Langa; Alain Koyama; Sarah R Preis; John Neuhaus; Ryan J McCammon; Kristine Yaffe; Sudha Seshadri; Mary N Haan; David R Weir
Journal:  Alzheimers Dement       Date:  2014-02-01       Impact factor: 21.566

7.  Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; George Papadopoulos; Genovefa Kolovou
Journal:  Methods Mol Biol       Date:  2018

8.  The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results.

Authors:  D L Braff; R Heaton; J Kuck; M Cullum; J Moranville; I Grant; S Zisook
Journal:  Arch Gen Psychiatry       Date:  1991-10

Review 9.  Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness.

Authors:  Takashi Tarumi; Rong Zhang
Journal:  J Neurochem       Date:  2017-11-07       Impact factor: 5.372

10.  Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study.

Authors:  Angela Rosenbohm; Benjamin Schmid; Dominik Buckert; Wolfgang Rottbauer; Jan Kassubek; Albert C Ludolph; Peter Bernhardt
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.